Source: Eur Respir J 2012; 39: 721-729
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sukkar M.B., Wood L.G., Tooze M., Simpson J.L., McDonald V.M., Gibson P.G., Wark P.A.B.. Soluble RAGE is deficient in neutrophilic asthma and COPD. Eur Respir J 2012; 39: 721-729

Member's Comments

No comment yet.

Related content which might interest you: Reduced soluble receptor for advanced glycation end-products in COPD Source: Eur Respir J 2011; 37: 516-522 Year: 2011 Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021 Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Increased expression of receptor for advanced glycation end products in COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015 Late Breaking Abstract - Increased advanced glycation end-products (AGEs) accumulation in skin is a risk factor lung function deterioration in asthmatic patients- preliminary data Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Signalling through the receptor for advanced glycation end products (RAGE) is increased in acute asthma and correlates with symptom severity Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Advanced glycation endproducts (AGE) contribute to the expression of pro-fibrotic cytokines and collagen production in a cell type dependent manner Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006 Receptor for advanced glycation end products (RAGE) is involved in cigarette smoke induced inflammation and emphysema Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Plasma advanced glycation end-products and skin autofluorescence are increased in COPD Source: Eur Respir J 2014; 43: 430-438 Year: 2013 Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Role of peroxiredoxin 6 in lipopolysaccharide-induced mucin production in mice Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013 Year: 2013 Advanced glycation endproducts are increased in lung tissue from patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Importance of the receptor for advanced glycation end products in the respiratory mechanics Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages Source: International Congress 2016 – Mechanisms of disease Year: 2016 LSC 2011 Abstract: P2Y2 receptor regulates VCAM-1 membrane and soluble forms and eosinophil accumulation during lung inflammation Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Measures of lung function and their relationship with advanced glycation end-products Source: ERJ Open Res, 6 (2) 00356-2019; 10.1183/23120541.00356-2019 Year: 2020 A role of the advanced glycation end products (AGEs) in epithelial-myofibroblast transition Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Alterations in gene expression of RAGE and its sheddases in blood of COPD patients do not relate to decreased plasma (e)sRAGE levels Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Plasma levels of soluble RAGE are lower in COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009